UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012830
Receipt No. R000014638
Official scientific title of the study The high-dose intravenous immunoglobulin administration examination for high sensitization renal transplantation candidates.
Date of disclosure of the study information 2014/01/14
Last modified on 2019/01/17 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The high-dose intravenous immunoglobulin administration examination for high sensitization renal transplantation candidates.
Title of the study (Brief title) high dose IVIg for high sensitized renal transplantation.
Region
Japan

Condition
Condition high sensitized renal transplantation candidates
Classification by specialty
Nephrology Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 avoiding Antibody mediated rejection
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes I perform kidney biopsy after transplant in approximately three months and confirm it pathologically.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 2-4 g/kg globulin is administrated in perioperative five days.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
10 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria positive crossmatch
high level of DSA
Key exclusion criteria heart failure
Target sample size 10

Research contact person
Name of lead principal investigator Yuki Miyauchi
Organization Ehime University
Division name department of Urology
Address Shitsukawa, Toon, Ehime
TEL 089-960-5356
Email uroyuukictb12@yahoo.co.jp

Public contact
Name of contact person Toxhiro Nakatsuka
Organization Ehime University
Division name Medical department research partnership division
Address Shitsukawa, Toon, Ehime
TEL 089-960-5172
Homepage URL
Email rinri@m.ehime-u.ac.jp

Sponsor
Institute Ehime University
Institute
Department

Funding Source
Organization Ehime University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 14 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 11 Month 25 Day
Anticipated trial start date
2013 Year 11 Month 25 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 01 Month 12 Day
Last modified on
2019 Year 01 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014638